Immune modulation by parasites is now a well recognized phenomenon. In the case of helminth parasites, such modulation results in a stable and predominantly Th-2 type environment. While this permits parasite survival in a less hostile immunological background, the host also benefits by generating lesser inflammatory responses and by indirectly providing protection against Th-1 type autoimmune diseases.
My primary research interests are in the characterization of complex glycans from Th-2 immunomodulatory helminth parasites (schistosomes, tapeworms) and evaluation of their immunoprotective and immunotherapeutic potentials. We have isolated Taenia crassiceps glycans that are therapeutic in cutaneous leishmaniasis. Our results also show that the protective and therapeutic effects of these glycans are mediated by Lewis X type fucosylated sugars.
Relevant references
1. Jang Lee J., Dissanayake S, Morris HR, Dell A. Haslam SM (2005) Mass spectrometric characterisation of Taenia crassiceps metacestode N-glycans. Molecular and Biochemical Parasitology. (Press).
2. Dissanayake S. (2005) Immunomodulation in parasitic infections: Parasite products as prototype immunotherapeutic agents. Emirates Medical Journal. 23: 117-124.
3. Dissanayake S. et al.. (2005) Adjuvant effect of Taenia crassiceps glycans against leishmanial antigens in mice infected with Leishmania mexicana. Molecular Immunology 42: 1495-1502.
4. Dissanayake S et al. (2004). Taenia crassiceps carbohydrates stimulate IL-6 expression in naive murine macrophages via Toll-like receptors (TLRs). Molecular Immunology, 41: 391-398.
5. Dissanayake S et al. (2004). Induction of IgG1, interleukin-6 and interleukin-10 by Taenia crassiceps metacestode carbohydrates. Immunology,107: 411-419.